The US-EU free trade pact and the Trans-Pacific Partnership are about securing regulatory gains for major corporate interests – Published on AlterNet, by Dean Baker, (first on AlJazeeraEnglish), April 29, 2013.
In polite circles in the United States, support for free trade is a bit like proper bathing habits: It is taken for granted. Only the hopelessly crude and unwashed would not support free trade.
There is some ground for this attitude. Certainly, the US has benefited enormously by being able to buy a wide range of items at lower cost from other countries. However, this does not mean that most people in the country have always benefited from every opening to greater trade … //
… All the arguments that trade economists make against tariffs and quotas apply to patent and copyright protection. The main difference is the order of magnitude. Tariffs and quotas might raise the price of various items by 20 or 30 percent. By contrast, patent and copyright protection is likely to raise the price of protected items 2,000 percent or even 20,000 percent above the free market price. Drugs that would sell for a few dollars per prescription in a free market would sell for hundreds or even thousands of dollars when the government gives a drug company a patent monopoly.
In the case of drug patents, the costs go beyond just dollars and cents. Higher drug prices will have a direct impact on the public’s health, especially in some of the poorer countries that might end up being parties to these agreements.
There are also a wide variety of regulatory issues that are being pursued through these agreements in large part because there would be difficulty getting them accepted through the normal political process. For example, the sort of government mandated internet policing that was part of the shipwrecked Stop Online Piracy Act is likely to reappear in one or both agreements.
It is also likely that rules that limit the power of governments to restrict fracking could be in the agreements. Such rules could prohibit not only the federal government, but also state or county governments, from imposing restrictions designed to protect the public’s health.
These are the sorts of restrictions that may appear in the TPP and US-EU Free Trade Agreement. The reason for using tentative language is that none of the specifics of the deal have yet been made public. The Obama administration is negotiating these pacts in secret. It has made almost nothing about the negotiating process public and has shared none of the proposed text with the relevant committees in Congress ( Public Citizen has posted information on the TPP based on leaked documents).
Incredibly, it has shared portions of the proposed TPP with the relevant industry groups. While elected representatives in Congress may not be able to find out anything about proposed rules on drug patents or restrictions on fracking, Pfizer and Merck will have the opportunity to weigh in on patent rules and the major oil and gas companies will help to draft language on fracking that serves their interests.
Divided Cyprus: Banking Crisis Awakens Hopes for Reconciliation, on Spiegel Online International, by Ulrike Putz in Gemikonagi, May 01, 2013 (Photo Gallery). The Greek half of Cyprus has been hard-hit by the banking crisis — and now hopes are growing in the Turkish north for reconciliation. If the two populations could resolve their dispute, they could likely access large natural gas reserves estimated to be worth hundreds of billions of euros …;
High-Profile Catalyst: Tough Times Ahead for German Tax Evaders, Part 1, on Spiegel Online International, April 30, 2013 (Photo Gallery): The case of Bayern Munich President Uli Hoeness is heating up the German election campaign and presenting a challenge to the courts, which have gone easy on wealthy tax offenders until now. The high-profile case is likely to mean harsher punishments in the future …;